Donor chimerism and stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: Effects of a retroviral-mediated gene transfer protocol and implications for gene therapy

Experimental Hematology

Volumn 30, Issue 11, 2002, Pages 1324-1332

  Goebel, W Scott ^a   Yoder, Mervin C ^a   Pech, Nancy K ^a   Dinauer, Mary C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL POPULATION; CHIMERA; CONTROLLED STUDY; DRUG EFFECT; GENE TRANSFER; LOW ENERGY RADIATION; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ANIMALS; ANIMALS, CONGENIC; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; FLUOROURACIL; GENES, REPORTER; GENETIC VECTORS; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; RADIATION CHIMERA; RADIATION DOSAGE; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; STEM CELL FACTOR; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TRANSFECTION; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0036840102     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00927-X     Document Type: Article

References (54)

1. Weinberg K., Kohn D. Gene therapy for congenital immunodeficiency diseases. Immunol Allergy Clin North Am. 16:1996;453.
2. Dunbar C. Gene transfer to hematopoietic stem cells. implications for gene therapy of human disease Annu Rev Med. 47:1996;11.
3. Kume A., Hanazono Y., Mizukami H., Urabe M., Ozawa K. Hematopoietic stem cell gene therapy. a current overview Int J Hematol. 69:1999;227.
4. Khouri I.F., Keating M., Korbling M.et al. Transplant-lite. induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol. 16:1998;2817.
5. Slavin S., Nagler A., Naparstek E.et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 91:1998;756.
6. Childs R.W., Clave E., Tisdale J., Plante M., Hensel N., Barrett J. Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant. evidence for a graft-versus-tumor effect J Clin Oncol. 17:1999;2044.
7. Childs R., Chernoff A., Contentin N.et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med. 343:2000;750.
8. Amrolia P., Gaspar H.B., Hassan A.et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood. 96:2000;1239.
9. Horwitz M.E., Barrett A.J., Brown M.R.et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med. 344:2001;881.
10. Brecher G., Ansell J., Micklem H., Tjio J., Cronkite E. Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci U S A. 79:1982;5085.
11. Saxe D., Boggs S., Boggs D. Transplantation of chromosomally marked syngeneic marrow cells into mice not subjected to hematopoietic stem cell depletion. Exp Hematol. 12:1984;277.
12. Wu D.-D., Keating A. Hematopoietic stem cells engraft in untreated transplant recipients. Exp Hematol. 21:1993;251.
13. Stewart F., Crittenden R., Lowry P., Pearson-White S., Quesenberry P. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood. 8:1993;2566.
14. Tomita Y., Sachs D., Sykes M. Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood. 83:1994;939.
15. Ramshaw H., Roa S., Crittenden R., Peters S., Weier H.-U., Quesenberry P. Engraftment of bone marrow cells into normal unprepared hosts. effects of 5-fluorouracil and cell cycle status Blood. 86:1995;924.
16. van Os R., Dawes D., Mislow J., Witsell A., Mauch P. Host conditioning with 5-fluorouracil and kit-ligand to provide for long-term bone marrow engraftment. Blood. 89:1997;2376.
17. Stewart F., Zhong S., Wuu J., Hsieh C., Nilsson S., Quesenberry P. Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood. 91:1998;3681.
18. Peters S.O., Kittler E.L., Ramshaw H.S., Quesenberry P.J. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood. 87:1996;30.
19. Schiffmann R., Medin J., Ward J., Stahl S., Cottler-Fox M., Karlsson S. Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients. successful engraftment and long-term expression of the transgene Blood. 86:1995;1218.
20. Kittler E., Peters S., Crittenden R.et al. Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts. Blood. 90:1997;865.
21. Mardiney M., Jackson S., Spratt S., Li F., Holland S., Malech H. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood. 89:1997;2268.
22. Bienzle D., Abrams-Ogg A., Kruth S.et al. Gene transfer into hematopoietic stem cells. long-term maintenance of in vitro activated progenitors without marrow ablation Proc Natl Acad Sci U S A. 91:1994;350.
23. Barquinero J., Kiem H., von Kalle C.et al. Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs. Blood. 85:1995;1195.
24. Kiem H., Andrews R., Morris J.et al. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, flt-3 ligand, and megakaryocyte growth and development factor. Blood. 92:1998;1878.
25. Tisdale J.F., Hanazono Y., Sellers S.E.et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood. 92:1998;1131.
26. Mardiney M., Malech H. Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation. implications for gene therapy Blood. 87:1996;4049.
27. Lerner C., Harrison D.E. 5-fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol. 18:1990;114.
28. Harrison D.E. Competitive repopulation. a new assay for long-term stem cell functional capacity Blood. 55:1980;77.
29. Harrison D.E., Jordan C.T., Zhong R.K., Astle C.M. Primitive hemopoietic stem cells. direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations Exp Hematol. 21:1993;206.
30. Bjorgvinsdottir H., Ding C., Pech N., Gifford M., Li L., Dinauer M. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood. 89:1997;41.
31. Dinauer M., Li L., Bjorgvinsdottir H., Ding C., Pech N. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease. Blood. 94:1999;914.
32. Haneline L., Gobbett T., Ramani R.et al. Loss of fancc function results in decreased hematopoietic stem cell repopulating ability. Blood. 94:1999;1.
33. Markowitz D., Goff S., Bank A. A safe packaging line for gene transfer. separating viral genes on two different plasmids J Virol. 62:1988;1120.
34. phox. Blood. 88:1996;1834.
35. phox cDNA and functional expression in a human X-linked chronic granulomatous disease cell line. Blood. 87:1996;2005.
36. Orlic D., Bodine D.M. What defines a pluripotent hematopoietic stem cell (PHSC). will the real PHSC please stand up! Blood. 84:1994;3991.
37. Miller D.G., Adam M.A., Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 10:1990;4239.
38. Hanenberg H., Ziag X., Dilloo D., Hashino K., Kato I., Williams D. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med. 2:1996;876.
39. Peters S.O., Kittler E.L., Ramshaw H.S., Quesenberry P.J. Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp Hematol. 23:1995;461.
40. Ploemacher R.E., van Os R., van Beurden C.A., Down J.D. Murine haemopoietic stem cells with long-term engraftment and marrow repopulating ability are more resistant to gamma-radiation than are spleen colony forming cells. Int J Radiat Biol. 61:1992;489.
41. Down J., Ploemacher R. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets. differential effects of host conditioning with gamma radiation and cytotoxic drugs Exp Hematol. 21:1993;913.
42. Grahn D., Hamilton K.F. Genetic variation in the acute lethal response of four inbred mouse strains to whole body x-irradiation. Genetics. 42:1957;189.
43. Roderick T.H. The response of twenty-seven inbred strains of mice to daily doses of whole body x-irradiation. Radiat Res. 20:1963;631.
44. Okayasu R., Suetomi K., Yu Y.et al. A deficiency in DNA repair and DNA-pkcs expression in the radiosensitive BALB/c mouse. Cancer Res. 60:2000;4342.
45. de Haan G., Nijhof W., Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging. correlation between lifespan and cycling activity Blood. 89:1997;1543.
46. de Haan G., Van Zant G. Intrinsic and extrinsic control of hemopoietic stem cell numbers. mapping of a stem cell gene J Exp Med. 186:1997;529.
47. van Os R., Sheridan T.M., Robinson S., Drukteinis D., Ferrara J.L., Mauch P.M. Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model. Stem Cells. 19:2001;80.
48. Nilsson S., Dooner M., Tiarks C., Weier H.-U., Quesenberry P. Potential distribution of transplanted hematopoietic stem cells in a nonablated mouse model. Blood. 89:1997;4013.
49. Kaufman C., Colson Y., Wren S., Watkins S., Simmons R., Ildstad S. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood. 84:1994;2436.
50. Neipp M., Zorina T., Domenick M., Exner B., Ildstad S. Effect of flt3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopietic stem cells in mice. kinetics and repopulating potential Blood. 92:1998;3177.
51. Rao S.S., Peters S.O., Crittenden R.B., Stewart F.M., Ramshaw H.S., Quesenberry P.J. Stem cell transplantation in the normal nonmyeloablated host. relationship between cell dose, schedule, and engraftment Exp Hematol. 25:1997;114.
52. Hesdorffer C., Ayello J., Ward M.et al. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol. 16:1998;165.
53. Qin S., Ward M., Raftopoulos H.et al. Competitive repopulation of retrovirally transduced haemopoietic stem cells. Br J Haematol. 107:1999;162.
54. Varas F., Bernard A., Bueren J.A. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors. Exp Hematol. 26:1998;100.